In Vivo CRISPR Screening in Head and Neck Cancer Reveals Uchl5 As an Immunotherapy Target

Scientists performed an in vivo CRISPR screen in an head and neck squamous cell carcinoma mouse model to identify immune evasion genes. They identified several regulators of immune checkpoint blockade response, including the ubiquitin C-terminal hydrolase 5 (UCHL5).